Performance of 18 F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resi...
Performance of 18 F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer
About this item
Full title
Author / Creator
Publisher
Germany
Journal title
Language
English
Formats
Publication information
Publisher
Germany
Subjects
More information
Scope and Contents
Contents
F-Fluciclovine is indicated for evaluation of suspected prostate cancer (PCa) biochemical recurrence. There are few studies investigating fluciclovine with PET/MR and none evaluated osseous metastases. Our aim was to assess the performance of
F-fluciclovine PET/MR (fluciclovine-PET/MR) for detecting osseous metastases in patients with castration...
Alternative Titles
Full title
Performance of 18 F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_31492992
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31492992
Other Identifiers
E-ISSN
1619-7089
DOI
10.1007/s00259-019-04506-1
